Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin

Journal of Clinical Microbiology

Volumn 45, Issue 7, 2007, Pages 2123-2125

  Affolabi, Dissou ^a,b   Odoun, Mathieu ^a   Martin, Anandi ^b   Palomino, Juan Carlos ^b   Anagonou, Séverin ^a   Portaels, Françoise ^b  

^a Laboratoire de Référence des Mycobactéries   (Benin)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE REDUCTASE; RIFAMPICIN;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BENIN; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE ASSAY; NONHUMAN; PRIORITY JOURNAL; SPUTUM ANALYSIS; SPUTUM SMEAR;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BENIN; COLORIMETRY; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34547625536     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00691-07     Document Type: Article

References (22)

1. Altman, D. G. 1999. Practical statistics for medical research. Chapman & Hall/CRC, London, United Kingdom.
2. Altman, D. G., and J. M. Bland. 1994. Diagnostic tests 2: predictive values. BMJ 309:102.
3. Angeby, K. A., L. Klintz, and S. E. Hoffner. 2002. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40:553-555.
4. Aziz, M. A., A. Wright, A. Laszlo, A. De Muynck, F. Portaels, A. Van Deun, C. Wells, P. Nunn, L. Blanc, M. Raviglione, and WHO/International Union against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2006. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-Tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154.
5. Canetti, G., W. Fox, A. Khomenko, H. T. Malher, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43.
6. Canetti, G., N. Rist, and J. Grosset. 1963. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Rev. Tuberc. Pneumol. 27:217-272.
7. Coban, A. Y., A. Birinci, B. Ekinci, and B. Durupinar. 2004. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int. J. Antimicrob. Agents 24:304-306.
8. Gamboa, F., P. J. Cardona, J. M. Manterola, J. Lonca, L. Matas, E. Padilla, J. R. Manzano, and V. Ausina. 1998. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and non respiratory clinical samples. Eur. J. Clin. Microbiol. Infect. Dis. 17:189-192.
9. Giampaglia, C. M., M. C. Martins, V. T. Inumaru, I. V. Butuem, and M. A. Telles. 2005. Evaluation of a rapid differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitrobenzoic acid and thiophene-2-carboxylic acid hydrazide. Int. J. Tuberc. Lung Dis. 9:206-209.
10. Golyshevskaia, V. I., A. A. Korneev, L. N. Chernousova, L. G. Selina, T. A. Kazarova, T. D. Grishina, S. G. Safonova, V. A Puzanov, G. M. Nikolaeva, and N. I. Fadeeva. 1996. New microbiological techniques in diagnosis of tuberculosis. Probl. Tuberk. 6:22-25. (In Russian.)
11. Hoffner, S. E., S. B. Svenson, R. Norberg, F. Dias, S. Ghebremichael, and G. Kallenius. 1993. Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau. J. Clin. Microbiol. 31:2215-2217.
12. Kallenius, G., T. Koivula, S. Ghebremichael, S. E. Hoffner, R. Norberg, E. Svensson, F. Dias, B. I. Marklund, and S. B. Svenson. 1999. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J. Clin. Microbiol. 37:3872-3878.
13. Lemus, D., E. Montoro, M. Echemendia, A. Martin, F. Portaels, and J. C. Palomino. 2006. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J. Med. Microbiol. 55:861-863.
14. Martin, A., J. C. Palomino, and F. Portaels. 2005. Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J. Clin. Microbiol. 43:1612-1616.
15. Musa, H. R., M. Ambroggi, A. Souto, and K. A. Angeby. 2005. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J. Clin. Microbiol. 43:3159-3561.
16. Rigouts, L., O. Nolasco, P. de Rijk, E. Nduwamahoro, A. Van Deun, A. Ramsay, J. Arevalo, and F. Portaels. 2007. Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:252-254.
17. Solis, L. A., S. S. Shin, L. L. Han, F. Llanos, M. Stowell, and A. Sloutsky. 2005. Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int. J. Tuberc. Lung Dis. 9:760-764.
18. Traore, H., K. Fissette, I. Bastian, M. Devleeschouwer, and F. Portaels. 2000. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 4:481-484.
19. World Health Organization. 1998. Laboratory services in tuberculosis control. Part III. Culture. WHO, Geneva, Switzerland.
20. World Health Organization. 1998. Laboratory services in tuberculosis control. Part II. Microscopy. WHO, Geneva, Switzerland.
21. World Health Organization. 2004. The WHO/IUATLD global project on antituberculosis drug resistance surveillance. Antituberculosis drug resistance in the world, report no. 3. WHO/HTM/TB/2005.349. WHO, Geneva, Switzerland.
22. Yang, B., H. Koga, H. Ohno, K. Ogawa, M. Fukuda, Y. Hirakata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno. 1999. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 42:621-628.